Evidence-Based Medicine Guidelines
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome. Accessed September 18, 2020.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. Retrieved September 18, 2020, from https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome
Antiplatelet and Anticoagulant Agents for Secondary Prevention of Stroke and Other Thromboembolic Events in People With Antiphospholipid Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2020 September 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
ID - 1305201
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305201/all/Antiplatelet_and_anticoagulant_agents_for_secondary_prevention_of_stroke_and_other_thromboembolic_events_in_people_with_antiphospholipid_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
